ANIP
ANIP clinical trials: ANI PHARMACEUTICALS INC
Every trial on ClinicalTrials.gov where ANI PHARMACEUTICALS INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 3
- Trials linked
- 1
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
ANIP on the catalyst calendar · ANIP registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Nov 30, 2027Sponsor estimate | NCT07938164ACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis...ANI Pharmaceuticals · Acute Gouty Arthritis | ANIPLead | Phase 4 | Recruiting | Locked | Locked | Locked |
| Mar 31, 2026Actual | NCT05486468The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentTexas Retina Associates · Uveitis | ANIPCollaborator | Phase 3 | Completed | Locked | Locked | Locked |
| Aug 31, 2027Sponsor estimate | NCT07346079Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresMassachusetts General Hospital · Gout Arthritis | ANIPCollaborator | Phase 4 | Recruiting | Locked | Locked | Locked |
- Primary completion Nov 30, 2027Sponsor estimatePhase 4NCT07938164ACUTE-GO is a Study Testing the Effectiveness and Safety of Two Doses of Purified Cortrophin Gel in Patients With Acute Gouty Arthritis...ANI Pharmaceuticals · Acute Gouty ArthritisRecruitingANIPLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2026ActualPhase 3NCT05486468The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentTexas Retina Associates · UveitisCompletedANIPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2027Sponsor estimatePhase 4NCT07346079Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresMassachusetts General Hospital · Gout ArthritisRecruitingANIPCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 3 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner